NASDAQ:VKTX | News — Page 2 | Viking Therapeutics, Inc.

VKTX News — Page 2

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2015-10-20Current reportSEC filingViking Therapeutics, Inc. filed Form 8-KViking Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2015-09-18Current reportSEC filingViking Therapeutics, Inc. filed Form 8-KViking Therapeutics, Inc. filed Form 8-K covering items 5.02.
2015-09-01Current reportSEC filingViking Therapeutics, Inc. filed Form 8-KViking Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2015-08-13Current reportSEC filingViking Therapeutics, Inc. filed Form 8-KViking Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2015-07-10Current reportSEC filingViking Therapeutics, Inc. filed Form 8-KViking Therapeutics, Inc. filed Form 8-K covering items 1.01,2.03.
2015-06-04Current reportSEC filingViking Therapeutics, Inc. filed Form 8-KViking Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2015-05-29Current reportSEC filingViking Therapeutics, Inc. filed Form 8-KViking Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.